Replies to post #173867 on Amarin Corp Plc (AMRN)

[Anonymous Fish]

Can anyone cite any examples of a drug being recommended as a standard of care by the AHA or AMA before the FDA had approved the drug label for it's use?

Thanks.

[jessellivermore]

sam81...

With you all the way brother...

The "Hoople Heads" are out in force this morning..Same old .same old.."Lookee, lookee, he's a buyen"...The EPA shipment must of come in rancid..Can't get it through their thick skulls that biotech management does not buy shares in the open market..because options, warrants and shares are the basis of their remuneration... IE. in lieu of money...They do sell shares however because Amazon does not take Amarin shares and most likely neither does their landlord...Or maybe the guy wants to buy an NSX..

The real money does not pour in until Vascepa becomes "Standard of Care" (SOC)...And that is a couple of major presentations and a label expansion away...The good news here is the likelihood this is going to happen sometime this year...Which I understand is longer than some of you impatient types can keep it in your pants...

":>) JL

[MNBioMike]

IMO, some good buying opportunities coming up in Feb/March.

Script # is embarrassing low. Everyone keeps making excuses for the crappy numbers (ie they're following a similar trend as prior years, etc), but what they're forgetting is that the biggest news in CVD in 30 years was released in Sept/Nov. Scripts should be EXPLODING, irregardless of whether it's January. Remember how many cards were in attendance at the AHA that were going to immediately start writing V? Thousands! This is the low hanging fruit period. The company should be on the airwaves daily, but they haven't been. They should be sprinting with the marketing blitz that they had years to plan for, but they're just strolling, if that.....

This is not an indictment on V, it's a home run. I've actually moved some of my EXAS position to AMRN in the past month because I think it's the best growth story out there, but I continue to be underwhelmed by the management group. They move slow and appear unprepared for a position they had years to plan for. Best guess is they're getting really low offers from BP, which haven't moved the wheels at all, so they're "not picking up the phone", and have continued to focus on the sNDA.

Should still be an incredible 2019, but the pace that these guys move and the strategy around marketing, IMO, one of the most valuable assets in the world, is mind boggling.